Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer have?
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer has 3 citations in the OpenAlex counts ScholarIQ stores.
When was Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer published?
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer has 2022 year in the ScholarIQ index.
What is the open-access status of Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer?
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer has green oa status in the ScholarIQ index.
What is the DOI of Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer?
The DOI for Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer is on the source record.
What is the PMID of Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer?
The PMID for Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer is on the source record.
What is the OpenAlex record for Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer?
The OpenAlex for Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer is on the source record.